276 related articles for article (PubMed ID: 25656775)
1. The role of hypercoagulability in ischemic colitis.
Tsimperidis AG; Kapsoritakis AN; Linardou IA; Psychos AK; Papageorgiou AA; Vamvakopoulos NC; Kyriakou DS; Potamianos SP
Scand J Gastroenterol; 2015 Jul; 50(7):848-55. PubMed ID: 25656775
[TBL] [Abstract][Full Text] [Related]
2. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
[TBL] [Abstract][Full Text] [Related]
3. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
Gokalp D; Tuzcu A; Bahceci M; Ayyildiz O; Yurt M; Celik Y; Alpagat G
Pituitary; 2011 Jun; 14(2):168-73. PubMed ID: 21107737
[TBL] [Abstract][Full Text] [Related]
4. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
Jusić A; Balić D; Avdić A; Pođanin M; Balić A
Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss.
Borsi E; Potre O; Ionita I; Samfireag M; Secosan C; Potre C
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674167
[No Abstract] [Full Text] [Related]
6. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
[TBL] [Abstract][Full Text] [Related]
7. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
8. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
Russo PD; Damante G; Pasca S; Turello M; Barillari G
Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
[TBL] [Abstract][Full Text] [Related]
12. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.
Glueck CJ; Bell H; Vadlamani L; Gupta A; Fontaine RN; Wang P; Stroop D; Gruppo R
Arch Ophthalmol; 1999 Jan; 117(1):43-9. PubMed ID: 9930159
[TBL] [Abstract][Full Text] [Related]
13. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
[TBL] [Abstract][Full Text] [Related]
14. The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease.
Yalım Z; Tutgun Onrat S; Alan S; Aldemir M; Avşar A; Doğan İ; Onrat E
Turk Kardiyol Dern Ars; 2020 Jul; 48(5):484-493. PubMed ID: 32633259
[TBL] [Abstract][Full Text] [Related]
15. Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations.
Ozdemir O; Yenicesu GI; Silan F; Köksal B; Atik S; Ozen F; Göl M; Cetin A
Genet Test Mol Biomarkers; 2012 Apr; 16(4):279-86. PubMed ID: 22047507
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study.
Ranellou K; Paraskeva A; Kyriazopoulos P; Batistatou A; Evangelou A; El-Aly M; Zis P; Tavernarakis A; Charalabopoulos K
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):430-5. PubMed ID: 25699610
[TBL] [Abstract][Full Text] [Related]
17. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.
Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G
Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Thrombosis: A Case of Hereditary Thromboembolism.
Giofrè MC; Napoli F; La Rosa D; Caruso A; Laganà N; Orlando Settembrini L; Saitta A; Versace AG
Am J Case Rep; 2017 Nov; 18():1157-1159. PubMed ID: 29093435
[TBL] [Abstract][Full Text] [Related]
19. Interaction of thrombophilic SNPs in patients with unexplained infertility-multifactor dimensionality reduction (MDR) model analysis.
Milenkovic J; Milojkovic M; Mitic D; Stoimenov TJ; Smelcerovic Z; Stojanovic D; Vujic S; Bojanic N
J Assist Reprod Genet; 2020 Jun; 37(6):1449-1458. PubMed ID: 32399796
[TBL] [Abstract][Full Text] [Related]
20. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
